Direxion Daily S&P Biotech Bull 3X ETF (NYSEARCA:LABU) Shares Cross Below Two Hundred Day Moving Average – What’s Next?

Posted by Linda Flegge on Nov 6th, 2026

Shares of Direxion Daily S&P Biotech Bull 3X ETF (NYSEARCA:LABU – Get Free Report) passed below its 200-day moving average during trading on Thursday. The stock has a 200-day moving average of $217.76 and traded as low as $207.50. Direxion Daily S&P Biotech Bull 3X ETF shares last traded at $208.62, with a volume of 631,633 shares trading hands.

Direxion Daily S&P Biotech Bull 3X ETF Stock Down 20.0%

The stock’s 50 day moving average price is $254.12 and its two-hundred day moving average price is $217.76.

Institutional Investors Weigh In On Direxion Daily S&P Biotech Bull 3X ETF

Several hedge funds have recently added to or reduced their stakes in LABU. Ramsey Quantitative Systems purchased a new stake in Direxion Daily S&P Biotech Bull 3X ETF in the second quarter valued at $41,000. StoneX Group Inc. purchased a new position in shares of Direxion Daily S&P Biotech Bull 3X ETF during the 3rd quarter valued at about $241,000. Halbert Hargrove Global Advisors LLC purchased a new position in shares of Direxion Daily S&P Biotech Bull 3X ETF during the 3rd quarter valued at about $266,000. Valued Retirements Inc. purchased a new position in shares of Direxion Daily S&P Biotech Bull 3X ETF during the 2nd quarter valued at about $454,000. Finally, Revere Asset Management Inc acquired a new position in shares of Direxion Daily S&P Biotech Bull 3X ETF in the 2nd quarter valued at about $666,000.

Direxion Daily S&P Biotech Bull 3X ETF Company Profile

(Get Free Report)

The Direxion Daily S&P Biotech Bull 3X Shares (LABU) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times exposure to the S&P Biotechnology Select Industry Index. LABU was launched on May 28, 2015 and is managed by Direxion.